Three IPOs raised $495 million this week, led by iRhythm Technologies (IRTC), which popped 53% on its first day. The other two IPOs, CRISPR Therapeutics (CRSP) and Forterra (FRTA), priced below...read more
iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, raised $107 million in an upsized IPO by offering 6.3 million shares at $17, above the $13 to $15 range. It had originally planned to raise $75 million by offering 5.4...read more
Three IPOs are set to raise $518 million in the week ahead. LBO'd industrial pipe maker Forterra is by far the week's largest deal, while CRISPR Therapeutics will attempt to prove that gene editing is more than a pipe dream. High-growth heart monitoring company...read more
iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $75 million by offering 5.35 million shares at a price range of $13 to...read more
US IPO Weekly Recap: Two deals flounder while one soars
Three IPOs raised $495 million this week, led by iRhythm Technologies (IRTC), which popped 53% on its first day. The other two IPOs, CRISPR Therapeutics (CRSP) and Forterra (FRTA), priced below...read more
High-growth heart monitors: iRhythm Technologies prices upsized IPO above the range at $17
iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, raised $107 million in an upsized IPO by offering 6.3 million shares at $17, above the $13 to $15 range. It had originally planned to raise $75 million by offering 5.4...read more
US IPO Week Ahead: 3 IPOs feature industrial pipes and high-growth health care
Three IPOs are set to raise $518 million in the week ahead. LBO'd industrial pipe maker Forterra is by far the week's largest deal, while CRISPR Therapeutics will attempt to prove that gene editing is more than a pipe dream. High-growth heart monitoring company...read more
Heart monitoring as a service: iRhythm Technologies sets terms for $75 million IPO
iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, announced terms for its IPO on Friday. The San Francisco, CA-based company plans to raise $75 million by offering 5.35 million shares at a price range of $13 to...read more